Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management

Experimental and Molecular Pathology

Volumn 98, Issue 3, 2015, Pages 411-418

  Amin, Moein ^a   Lam, Alfred King yin ^a,b  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Metastases; Micro RNA; Oesophageal adenocarcinoma; Prognosis

Indexed keywords

MICRORNA;

BARRETT ESOPHAGUS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CHEMORADIOTHERAPY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; METASTASIS; MOLECULARLY TARGETED THERAPY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REVIEW; SQUAMOUS EPITHELIUM; SURVIVAL RATE; TREATMENT RESPONSE; UPREGULATION; CARCINOMA; ESOPHAGEAL NEOPLASMS; GENETICS; METABOLISM;

CARCINOGENESIS; CARCINOMA; ESOPHAGEAL NEOPLASMS; HUMANS; MICRORNAS;

EID: 84926377060     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.03.002     Document Type: Review

References (53)

1. Bansal A., Lee I.H., Hong X., Anand V., Mathur S.C., et al. Feasibility of mcroRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am. J. Gastroenterol. 2011, 106:1055-1063.
2. Chan K.W., Lee P.Y., Lam A.K., Law S., Wong J., Srivastava G. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma. J. Clin. Pathol. 2006, 59:101-104.
3. Chan D., Tsoi M.Y., Liu C.D., Chan S.H., Law S.Y., Chan K.W., Chan Y.P., Gopalan V., Lam A.K., Tang J.C. Oncogene GAEC1 regulates CAPN10 expression which predicts survival in oesophageal squamous cell carcinoma. World J. Gastroenterol. 2013, 19:2772-2780.
4. Chen Z., Saad R., Jia P., Peng D., Zhu S., et al. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer 2013, 119:1985-1993.
5. Chung Y., Lam A.K., Luk J.M., Law S., Chan K.W., Lee P.Y., Wong J. Altered E-cadherin expression and p120 catenin localization in oesophageal squamous cell carcinoma. Ann. Surg. Oncol. 2007, 14:3260-3267.
6. Derouet M.F., Liu G., Darling G.E. MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. PLoS One 2014, 9:e115589.
7. Ebrahimi F., Gopalan V., Smith R.A., Lam A.K. miR-126 in human cancers: clinical roles and current perspectives. Exp. Mol. Pathol. 2014, 96:98-107.
8. Fassan M., Pizzi M., Battaglia G., Giacomelli L., Parente P., et al. Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J. Clin. Pathol. 2010, 63:692-696.
9. Fassan M., Volinia S., Palatini J., Pizzi M., Baffa R., et al. MicroRNA expression profiling in human Barrett's carcinogenesis. Int. J. Cancer 2011, 129:1661-1670.
10. Fassan M., Pizzi M., Realdon S., Balistreri M., Guzzardo V., et al. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum. Pathol. 2013, 44:1804-1810.
11. Fatima S., Chui C.H., Tang W.K., Hui K.S., Au H.W., Li W.Y., Wong M.M., Cheung F., Tsao S.W., Lam K.Y., Beh P.S., Wong J., Law S., Srivastava G., Ho K.P., Chan A.S., Tang J.C. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human oesophageal squamous cell carcinoma. Int. J. Mol. Med. 2006, 17:159-170.
12. Feber A., Xi L., Luketich J.D., Pennathur A., Landreneau R.J., et al. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 2008, 135:255-260.
13. Feber A., Xi L., Pennathur A., Gooding W.E., Bandla S., et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann. Thorac. Surg. 2011, 91:1523-1530.
14. Garman K.S., Owzar K., Hauser E.R., Westfall K., Anderson B.R., et al. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig. Dis. Sci. 2013, 58:3178-3188.
15. Gopalan V., Pillai S., Ebrahimi F., Salajegheh A., Lam T.C., Le T.K., Langsford N., Ho Y.H., Smith R.A., Lam A.K. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol. Carcinog. 2014, 53:E36-E44.
16. Gopalan V., Smith R.A., Lam A.K. Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp. Cell Res. 2015, 330:423-428.
17. Hu Y., Correa A.M., Hoque A., Guan B., Ye F., et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 2011, 128:132-143.
18. Hummel R., Hussey D.J., Michael M.Z., Haier J., Bruewer M., et al. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann. Surg. Oncol. 2011, 18:253-260.
19. Hummel R., Watson D.I., Smith C., Kist J., Michael M.Z., et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J. Gastrointest. Surg. 2011, 15:429-438.
20. Kan T., Sato F., Ito T., Matsumura N., David S., et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136:1689-1700.
21. Ko M.A., Zehong G., Virtanen C., Guindi M., Waddell T.K., et al. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann. Thorac. Surg. 2012, 94:1094-1102.
22. Kumarasinghe M.P., Brown I., Raftopoulos S., Bourke M.J., Charlton A., de Boer W.B., Eckstein R., Epari K., Gill A.J., Lam A.K., Price T., Streutker C., Lauwers G.Y. Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations. Pathology 2014, 46:473-480.
23. Kwong D., Lam A., Guan X., Law S., Tai A., Wong J., Sham J. Chromosomal aberrations in oesophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum. Pathol. 2004, 35:309-316.
24. Lam A.K.Y. Critical review: molecular biology of oesophageal squamous cell carcinoma. Crit. Rev. Oncol. Hematol. 2000, 33:71-90.
25. Lam K.Y., Ma L. Pathology of oesophageal cancers: local experience and current insights. Chin. Med. J. 1997, 110:459-464.
26. Lam K.Y., Law S., Ma L.T., Ong S.K., Wong J. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?. Eur. J. Cancer 1997, 33:1221-1225.
27. Lam K.Y., Law S., Tung P.H., Wong J. Oesophageal basaloid squamous cell carcinoma: an unique clinicopathological entity with telomerase activity as a prognostic indicator. J. Pathol. 2001, 195:435-442.
28. Law F.B., Chen Y.W., Wong K.Y., Ying J., Tao Q., Langford C., Lee P.Y., Law S., Cheung R.W., Chui C.H., Tsao S.W., Lam K.Y., Wong J., Srivastava G., Tang J.C. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in oesophageal squamous cell carcinoma. Oncogene 2007, 26:5877-5888.
29. Leidner R.S., Ravi L., Leahy P., Chen Y., Bednarchik B., et al. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Gene Chromosome Cancer 2012, 51:473-479.
30. Luzna P., Gregar J., Uberall I., Radova L., Prochazka V., et al. Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn. Pathol. 2011, 6:114.
31. Lynam-Lennon N., Reynolds J.V., Marignol L., Sheils O.M., Pidgeon G.P., et al. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J. Mol. Med. (Berl.) 2012, 90:1449-1458.
32. Maroof H., Salajegheh A., Smith R.A., Lam A.K. Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis. Exp. Mol. Pathol. 2014, 97:298-304.
33. Maroof H., Salajegheh A., Smith R.A., Lam A.K. MicroRNA-34 family, mechanisms of action in cancer: a review. Curr. Cancer Drug Targets 2014, 14:737-751.
34. Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., et al. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol. 2009, 174:1940-1948.
35. Mathé E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009, 15:6192-6200.
36. Matsuzaki J., Suzuki H., Tsugawa H., Watanabe M., Hossain S., et al. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology 2013, 145:1300-1311.
37. Nguyen G.H., Schetter A.J., Chou D.B., Bowman E.D., Zhao R., et al. Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin. Cancer Res. 2010, 16:5824-5834.
38. Pak K.C., Lam K.Y., Law S., Tang J.C. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human oesophageal squamous cell carcinoma. Int. J. Mol. Med. 2009, 23:121-129.
39. Revilla-Nuin B., Parrilla P., Lozano J.J., de Haro L.F., Ortiz A., et al. Predictive value of MicroRNAs in the progression of Barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann. Surg. 2013, 257:886-893.
40. Saad R., Chen Z., Zhu S., Jia P., Zhao Z., et al. Deciphering the unique microRNA signature in human esophageal adenocarcinoma. PLoS One 2013, 8:e64463.
41. Skinner H.D., Lee J.H., Bhutani M.S., Weston B., Hofstetter W., et al. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 2014, 120:3635-3641.
42. Smith C.M., Watson D.I., Leong M.P., Mayne G.C., Michael M.Z., et al. miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. World J. Gastroenterol. 2011, 17:1036-1044.
43. Streppel M.M., Pai S., Campbell N.R., Hu C., Yabuuchi S., et al. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin. Cancer Res. 2013, 19:4067-4078.
44. Tang W.K., Chui C.H., Fatima S., Kok S.H., Pak K.C., Ou T.M., Hui K.S., Wong M.M., Wong J., Law S., Tsao S.W., Lam K.Y., Beh P.S., Srivastava G., Ho K.P., Chan A.S., Tang J.C. Inhibitory effects of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human oesophageal squamous cell carcinoma. Int. J. Mol. Med. 2007, 19:953-960.
45. Tang W.K., Chui C.H., Fatima S., Kok S.H., Pak K.C., Ou T.M., Hui K.S., Wong M.M., Wong J., Law S., Tsao S.W., Lam K.Y., Beh P.S., Srivastava G., Chan A.S., Ho K.P., Tang J.C. Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human oesophageal squamous cell carcinoma. Int. J. Mol. Med. 2007, 19:915-923.
46. Tong D.K., Law S., Kwong D.L., Chan K.W., Lam A.K., Wong K.H. Histological regression of squamous oesophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. Ann. Surg. Oncol. 2010, 17:2184-2192.
47. van Baal J.W., Verbeek R.E., Bus P., Fassan M., Souza R.F., et al. microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut 2013, 62:664-675.
48. Vosgha H., Salajegheh A., Smith R.A., Lam A.K. The important roles of miR-205 in normal physiology, cancers and as a potential therapeutic target. Curr. Cancer Drug Targets 2014, 14:621-637.
49. Wijnhoven B.P., Hussey D.J., Watson D.I., Tsykin A., Smith C.M., et al. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br. J. Surg. 2010, 97:853-861.
50. Wong M.L., Tao Q., Fu L., Wong K.Y., Qiu G.H., Law F.B., Tin P.C., Cheung W.L., Lee P.Y., Tang J.C., Tsao G.S., Lam K.Y., Law S., Wong J., Srivastava G. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Int. J. Oncol. 2006, 28:767-773.
51. Wu X., Ajani J.A., Gu J., Chang D.W., Tan W., et al. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer. Prev. Res. (Phila.) 2013, 6:196-205.
52. Yang H., Gu J., Wang K.K., Zhang W., Xing J., et al. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 2009, 15:5744-5752.
53. Zhang Y.F., Zhang A.R., Zhang B.C., Rao Z.G., Gao J.F., et al. MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway. Mol. Biol. Rep. 2013, 40:1711-1720.